ETON PHARMACEUTICALS INC. - COMMON STOCK
14.78
12-March-25 16:45:02
15 minutes delayed
Stocks
+0.68
+4.82%
Today's range
14.35 - 15.02
ISIN
N/A
Source
NASDAQ
-
04 Mar 2025 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
03 Mar 2025 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
07 Feb 2025 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
06 Feb 2025 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
03 Jan 2025 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
20 Dec 2024 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
17 Dec 2024 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
03 Dec 2024 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
25 Nov 2024 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
12 Nov 2024 16:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
07 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
06 Nov 2024 16:30:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
03 Oct 2024 06:30:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
22 Aug 2024 16:30:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
08 Aug 2024 16:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
30 Jul 2024 17:30:00 By Nasdaq GlobeNewswire
-
15 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
09 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
01 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
30 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >